Prostaglandin G/H synthases (PGHS), commonly referred to as cyclooxygenases (COX-1 and COX-2), catalyze a key step in the synthesis of biologically active prostaglandins (PGs), the conversion of arachidonic acid (AA) into prostaglandin H 2 (PGH 2 ). PGs have important functions in a variety of physiologic and pathologic settings, including inflammation, cardiovascular homeostasis, reproduction, and carcinogenesis. However, an evaluation of prostaglandin function in early development has been difficult due to the maternal contribution of prostaglandins from the uterus. The emergence of zebrafish as a model system has begun to provide some insights into the roles of this signaling cascade during vertebrate development. In zebrafish, COX-1 derived prostaglandins are required for two distinct stages of development, namely during gastrulation and segmentation. During gastrulation, PGE 2 signaling promotes cell motility, without altering the cell shape or directional migration of gastrulating cells. During segmentation, COX-1 signaling is also required for posterior mesoderm development, including the formation of vascular tube structures, angiogenesis of intersomitic vessels, and pronephros morphogenesis. We propose that deciphering the role for prostaglandin signaling in zebrafish development could yield insight and ultimately address the mechanistic details underlying various disease processes that result from perturbation of this pathway. D
Introduction
Prostanoids, comprised of prostaglandins (PGs) and thromboxanes (TXs), are oxygenated metabolites of C20 polyunsaturated fatty acids including arachidonic and eicosapentaenoic acids that are released from membrane phospholipids. Prostaglandins have been shown to play important roles in various physiological processes in invertebrates (Rowley et al., 2005; Stanley, 2000) , vertebrates (Cha et al., 2005; Evans and Gunderson, 1998; Grosser et al., 2002; Yang et al., 2002) , and mammals (Langenbach et al., 1999; Narumiya et al., 1999) , indicating that these bioactive lipid molecules are evoluntionarily conserved. Until now, most of the studies evaluating prostaglandin signaling have come from mammalian models. Analyses of genetic knockouts of cyclooxygenases and prostaglandin signaling components have led to significant progress in this field. This review will summarize the recent advances in the field of prostaglandin biology with a particular focus on the developmental role of these lipid mediators. In addition, we propose that zebrafish may provide a very useful model system to elucidate the precise role of prostaglandin signaling pathways and their biological endpoints in early development.
Historical perspective

Discovery of prostanoids
Seminal work in understanding the prostaglandin biosynthetic pathway came to light by elucidating the mechanism by which aspirin exerts its anti-inflammatory, analgesic, and antipyretic actions. In 1971, Sir John Vane showed that aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) inhibit the activity of the enzyme now known as cyclooxygenase (COX), leading to the formation of prostaglandins (PGs) that cause inflammation, swelling, pain, and fever (Vane, 1971) . Since this discovery there has been a fervent interest in understanding how cyclooxygenase signaling functions in both physiological and pathophysiological conditions. Long before we knew how aspirin worked, Kurzrok and Lieb (1930) first determined there was some biologic activity in semen when they observed violent contractions of the uterus following artificial insemination. In 1933 Goldblat reported that human semen contained a substance that both reduced blood pressure and stimulated smooth muscle (Goldblatt, 1933 (Goldblatt, , 1935 . At about the same time, von Euler and colleagues showed that a lipid soluble factor from semen could decrease blood pressure and stimulate smooth muscle contractions as well (Euler, 1935) . He named this substance ''prostaglandins'' assuming that it came from the prostate gland. Later, others were to find that this was not the case.
In the 1950s, Bergströ m, et al., made a breakthrough in the field by purifying the chemical compound of two major prostaglandins, PGE and PGF. He subsequently demonstrated that prostaglandins are formed from unsaturated fatty acids, primarily from arachidonic acid (Bergstrom, 1967) . In the 1960s, work by Samuelsson revealed the processes by which prostaglandins are metabolized and demonstrated the existence of two distinct pathways originating from arachidonic acid, one pathway leading to prostanoid formation, the other to the formation of leukotrienes (Bergstroem and Samuelsson, 1965) .
Not only did Vane's discovery lead to an improved understanding of how prostaglandins are synthesized, he provided the mechanistic insight that the NSAIDs bind directly to cyclooxygenase to inhibit prostaglandin production (Vane, 1971) . The mechanism of NSAID action was to either bind covalently to the active sites (aspirin) or to compete with substrate for the binding to the active site (most of the other NSAIDs) of the cyclooxygenase enzyme. In 1982, ''for their discoveries concerning prostaglandins and related biologically active substances,'' Bergströ m, Samuelsson, and Vane shared the Nobel prize in Medicine (Raju, 1999) .
Discovery of cyclooxygenase
Subsequently, extensive advances in molecular biology led to the isolation of Cox-1 cDNA, corresponding to a genetic locus that spanned 11 exons, covered 25 kb, and encoded a 2.8 -3.0 kb mRNA and 68-kDa protein (Yokoyama et al., 1988) . Interestingly, the levels of Cox-1 mRNA did not vary greatly in cell stimulation experiments. In fact, COX-1 was expressed constitutively in many tissues, including the kidney, lung, stomach, duodenum, jejunum, ileum, colon, and cecum of the rat, dog, Rhesus monkey, and human (Kargman et al., 1996) . These findings led to the hypothesis that COX-1 is the ''housekeeping'' enzyme responsible for basal, constitutive prostaglandin synthesis. For example, prostaglandins such as PGE 2 and PGI 2 appear critical for maintaining physiologic homeostasis.
The existence of a second cyclooxygenase was proposed when sheep epithelial cells were found to exhibit increased prostaglandin production following stimulation with growth factors (Rosen et al., 1989) . This also correlated with an increase in the amount of 4.0 kb mRNA that hybridized with Cox-1 cDNA. A fervent search commenced to identify a second cyclooxygenase enzyme, which was reported by at least three groups. In 1991, Simmons and colleagues identified COX-2 from src-transformed chicken fibroblasts, and determined that its sequence was 60-65% similar to that of sheep, mouse, and human COX-1 protein (Xie et al., 1991) . Cox-2 expression was also detected in src-transformed fibroblasts and in mouse fibroblasts treated with the tumor promoter tetradecanoylphorbolacetate (TPA) (Kujubu et al., 1991) and human endothelial cells or monocytes treated with TPA or lipopolysaccharide (LPS) (Hla and Neilson, 1992; O'Banion et al., 1991) . Most tissues did not express Cox-2 constitutively, but various intracellular and extracellular stimuli including cytokines, mitogens, growth factors, and tumor promoters could rapidly induce Cox-2 expression in many different cell lines. Researchers then began to postulate that COX-2 was an ''inducible'' enzyme that produces prostaglandins in a wide variety of inflammatory and carcinogenic settings. Hence, COX-2-selective inhibitors, such as CelebrexR and VioxxR, were developed to treat various inflammatory diseases and later evaluated for their potential as chemopreventive agents (Marnett and DuBois, 2002) .
Eicosanoid metabolism
Synthesis of prostanoids is initiated by the rate-limiting release of arachidonic acid from the plasma membrane by phospholipase A2. Arachidonic acid is then converted to PGH 2 by the enzymatic, two-step action of prostaglandin G/H synthase-1 or -2 (PGHS), commonly referred to as cyclooxygenase-1 and -2 (Fig. 1) . COX enzymes reside in the endoplasmic reticulum (ER) and nuclear membrane with the substrate-binding pocket precisely orientated to take up the released arachidonic acid. PGH 2 is isomerized by various tissue specific prostaglandin synthases to form active lipid molecules. Aside from the prostanoid pathway, arachidonic acid can also serve as a substrate for the formation of hydroxyeicosatatraenoic acids (HETEs), leukotrienes, and lipoxins by the action of lipooxygenase enzymes. A third pathway leads to production of epoxyarachidonic acid via the enzymatic activity of cytochrome P450 monooxygenase enzymes. The metabolic products from the three pathways are collectively known as eicosanoids from the Greek root of eikosi, meaning ''twenty'' for the 20-carbon fatty acid of arachidonate.
The crystal structures of COX-1 and COX-2 are remarkably similar, with one notable amino acid difference that allows for a larger ''side-pocket'' for substrate access in COX-2 (Smith et al., 2000) . PGH 2 is subsequently converted to one of several structurally related prostaglandins, including PGE 2 , PGD 2 , PGF 2a , PGI 2 (also known as prostacyclin), and TxA 2 (thromboxane A 2 ), by specific PG synthases (Funk, 2001 ). The coupling of PGH 2 synthesis to metabolism by downstream enzymes is intricately orchestrated in a cell-specific fashion. For example, thromboxane synthase is found mainly in platelets and macrophages, and TxA 2 stimulates platelet aggregation and vessel constriction. Whereas prostacyclin synthase is expressed in endothelial cells, its product, PGI 2 , is known for its cardioprotective properties that cause platelet de-aggregation and vessel dilation. PGF synthase is found in the uterus, and two types of PGD synthase are in brain and mast cells. Two PGE synthases have been described: microsomal PGE synthase (mPGES), a member of the MAPEG (Membrane-Associated Proteins in Eicosanoid and Glutathione metabolism) family (Schneider et al., 2004) , and cytosolic PGE synthase (cPGES). These two PGESs largely account for PGE 2 synthesis ( Fig. 1 ) in mammals.
Signaling downstream of cyclooxygenase in mammals
There are at least 9 known prostaglandin receptors in mammals, as well as several additional splice variants with divergent carboxy termini . Four of the receptor subtypes bind PGE 2 (EP1-EP4); two bind PGD 2 (DP1 and DP2) and the FP, IP, and TP receptors bind PGF 2a , PGI 2 , and TxA 2 , respectively. The prostaglandin receptors are categorized as three clusters of a distinct subfamily in the G protein-coupled receptor (GPCR) superfamily of seven transmembrane-spanning proteins. The lone exception is DP2, a member of the chemoattractant receptor subgroup. The ''stimulatory'' receptors including IP, DP1, EP2, and EP4 that signal through Gs-mediated increases in intracellular cyclic adenosine monophosphate (cAMP) form one cluster (Hirata et al., 1994a; Honda et al., 1993; Namba et al., 1994; Regan et al., 1994) ; the receptors EP1, FP, and TP form a second group that signals through Gq-mediated increases in intracellular calcium (Graves et al., 1995; Hirata et al., 1991; Namba et al., 1993) . Lastly, the EP3 receptor is regarded as an ''inhibitory'' receptor as it couples to Gi to decrease cAMP formation (Sugimoto et al., 1992) .
Other mechanisms, besides ligand -receptor binding on the plasma membrane, have been implicated in prostaglandin signaling. For example, there is evidence that EP receptors can be internalized into the nucleus (Bhattacharya et al., 1998 (Bhattacharya et al., , 1999 . EP3 and EP4 receptors have been shown to regulate gene transcription by modulating the release of calcium from nuclear calcium pools or by activation of calcium channels (Desai et al., 2000) . In addition, prostaglandin metabolites have also been shown to activate transcriptional targets directly by binding to peroxisome proliferator-activated receptors (PPARs), which are members of the orphan nuclear receptor superfamily that constitutively bind to the promoter elements of their target genes (Forman et al., 1997) . PGI 2 and PGJ 2 (a metabolite product of PGD 2 ) have been shown to bind PPAR y and PPARg, respectively, for direct activation of transcriptional targets. In view of its physiologic significance, gaining a detailed understanding of prostaglandin signaling becomes an especially important area of research. 
Cyclooxygenases and embryonic development
Even with our advanced understanding of prostaglandin signaling, we have not elucidated the precise role of these bioactive lipids during embryogenesis. So far, most of the work in non-mammalian systems has been focused on identification of functional COX homologues. PGs and other eicosanoids have been identified in both invertebrates and vertebrates. In invertebrates, eicosanoids mediate cellular immunity, play a role in fertility and regulate febrile response (Stanley, 2005) . Although COX-like enzymes have been identified in invertebrates, the exact mechanism of prostanoid biosynthesis is still under debate (Rowley et al., 2005) . In vertebrates, a COX-2 homologue has been cloned from rainbow trout (Zou et al., 1999) , and COX-1 and COX-2 homologues were identified from brook trout (Roberts et al., 2000) and dog fish shark (Yang et al., 2002) . In addition, the zebrafish COXs were shown to be genetically and functionally similar to the mammalian counterparts , indicating that the duplication of COX gene likely occurred before the emergence of cartilaginous fish.
In mice, inactivation of genes encoding COX enzymes via homologous recombination did not reveal much insight into the developmental role for prostaglandins. In heterozygous matings, Cox-1 null mice were born in the expected ratios and lived to a normal lifespan (Langenbach et al., 1995) . Surprisingly, these mutant mice were quite healthy given the putative ''housekeeping'' function of the COX-1 enzyme. However, Cox-1 null female mice demonstrated prolonged gestation periods and delayed parturition that ultimately resulted in a reduction in the number of viable progeny. The defective reproduction due to the loss of COX activity could be suppressed by the administration of PGF 2a (Gross et al., 1998) . This line of investigation suggested that COX-1 function was dispensable for ovulation, fertilization, and implantation of mouse embryos, but indispensable for fulfilling the normal labor term.
Cox-2 null mice demonstrated numerous developmental defects (Dinchuk et al., 1995) . Only 60% of the pups survived to weaning, and of those, only 75% survived to 1 year of age. Death after 3 weeks of age was mainly due to gastric peritonitis or kidney dysfunction, which suggested that certain somatic tissues require COX-2 derived prostaglandins for normal homeostasis. In addition, Cox-2 null females also demonstrated multiple reproductive defects, including ovulation, fertilization, implantation, and decidualization, indicating that COX-2 derived prostaglandins are also critical for multiples stages of reproduction (Lim et al., 1997) . Indeed, exogenous PGE 2 treatment can rescue the defects in ovulation in COX-2-deficient mice, demonstrating that proper follicle expansion and ovulation requires the synthesis of PGE 2 . Recently, the reproductive defects associated with Cox-2 inactivation in C57BL/6J/129 mice was introduced onto CD1 genetic background that had high endogenous expression of COX-1 in the reproductive organs (Wang et al., 2004) . This showed functional redundancy between COX enzymes and revealed that the levels of prostaglandins ultimately determine the success of reproduction cycle.
Prostaglandin receptors and development
Reproduction
The inactivation of genes encoding prostaglandin receptors by homologous recombination in mice revealed that IP-, EP1-, EP3-, EP4-, and TP-deficient females were essentially fertile, birthing embryos that develop normally. However, EP2-null female mice exhibited multiple reproductive defects similar to COX-2-deficient females (Hizaki et al., 1999; Kennedy et al., 1999; Tilley et al., 1999) , delivering fewer pups than their wildtype counterparts, irrespective of the genotypes of mating males. Ovulation was slightly impaired and fertilization dramatically reduced in EP2-deficient mice, leading to the hypothesis that the reproductive failure during early pregnancy in COX-2-deficient mice was due to lack of PGE 2 ligands available to bind to the EP2 receptor (Hizaki et al., 1999) . Gonadotropins induced the expression of EP2 receptor and COX-2 in the cumulus and elavated PGE 2 , in turn, stimulated cumulus expansion by elevating cAMP (Hizaki et al., 1999) . These studies demonstrated that the PGE 2 and EP2 receptor system work as a positive-feedback loop to induce the oophorus maturation required for fertilization, during and after ovulation.
PGF 2a has a well-recognized role for stimulating leuteolysis and uterine contraction, important for inducing labor and delivering pups during parturition, respectively. Consistently, generation of FP-deficient female mice demonstrated that they do not undergo parturition . Normally the luteolytic action of PGF 2a is required in mice to diminish progesterone levels and thus permit the initiation of labor. In FP null females, production of PGF 2a in intrauterine tissues during late pregnancy is significantly reduced and the administration of PGF 2a on day 19 is able to restore normal parturition . The important role of PGF 2a in uterine contraction is supported by studies of COX-1-deficient female mice, which exhibit a similar defect in parturition (Gross et al., 1998) . In wild-type mice, uterine expression of Cox-1 mRNA gradually increased from day 15 of pregnancy, reaching maximal levels on day 17 and rapidly decreasing after day 20, the day when parturition normally occurs. Ichikawa and colleagues found that these cycles are altered in FP-deficient mice and the uterine expression of Cox-1 mRNA was still elevated on day 20 of pregnancy (Tsuboi et al., 2000) . This observation suggested that progesterone withdrawal could serve as a negative feedback system for uterine COX-1 expression.
Ductus arteriosus
The ductus arteriosus is a normal fetal structure, allowing blood to bypass circulation through the lungs, since the fetus does not require its lungs for oxygenation (oxygen is provided through the mother's placenta), and blood flow is shunted from the left pulmonary artery to the aorta. In most cases, the ductus closes soon after birth, and its closure is stimulated by withdrawal of prostaglandins (which act as a dilator) as well as active contraction exerted by increased oxygen tension (Smith, 1998) . Administration of NSAIDs leads to closure of the ductus, emphasizing the role of prostaglandins in this process, and indeed, NSAIDs are now used to treat patent ductus arteriosus in neonates. Conversely, vasodilator PGs such as PGE 1 maintain the patency of the ductus in neonates with ductus arteriosus (Smith and McGrath, 1994) . A study using various synthetic PG analogs suggested that both IP and EP4 receptors are present in the ductus and are involved in maintaining the dilation of this vessel (Smith and McGrath, 1994) . EP4 receptor expression was confirmed by in situ hybridization of its mRNA in the mouse (Nguyen et al., 1997) . Although disruption of the mouse IP gene did not appear to cause any abnormality of the ductus , mice without EP4 receptors died within 3 days after birth, due to marked pulmonary congestion and heart failure (Nguyen et al., 1997) , likely resulting from a patent ductus. Administration of indomethacin to mice during late pregnancy elicited premature closure of the ductus in wild-type fetuses, but not in the ductus of EP4-deficient fetuses, indicating that the dilatory effect of PGE 2 on this vessel is mediated by the EP4 receptor (Nguyen et al., 1997 ). This finding is also supported by the phenotype of COX-1, COX-2 double knockout mice, which died shortly after birth due to a patent ductus arteriosus (Loftin et al., 2001) .
Cardiovascular homeostasis
Perhaps the most clinically recognized aspect of prostaglandin biology is its role in maintaining cardiovascular homeostasis. PGI 2 (prostacyclin) has well-known vasodilating and antithrombogenic properties that confer cardioprotective effects. PGI 2 acts on platelets to inhibit platelet aggregation and on smooth muscle cells of blood vessels to cause vasodilation. Analyses of mice deficient in the IP receptor revealed that their basal blood pressure and heart rate were not different from those of wild-type siblings . This result indicated that the PGI 2 and IP receptors do not work constitutively in regulating the systemic circulation but more likely work on demand, in response to local stimuli. Furthermore, IP-deficient mice developed and aged normally, without an increased occurrence of vascular incidents. However, an enhanced thrombotic activity was observed in IP-deficient mice in response to endothelial damage . These findings confirmed the proposed role of PGI 2 as an endogenous antithrombotic agent and suggest that this antithrombotic system is activated in response to vascular injury.
On the other hand, TxA 2 also acts on platelets to induce platelet aggregation and on smooth muscle cells of blood vessel to cause vasoconstriction. Because of their opposing effects on blood vessels and platelets, a precise balance between the PGI 2 and TxA 2 is probably important for maintaining vascular homeostasis (i.e., to prevent thrombosis and vasospasm while performing efficient hemostasis). TP-deficient mice showed increased bleeding tendencies and were resistant to cardiovascular shock induced by intravenous infusion of a TP agonist, U-46619, and arachidonic acid (Thomas et al., 1998) . The increased bleeding tendency had also been noted in mice harboring in the TP receptor an arginine to leucine missense mutation, which impairs coupling of the mutant receptor to Gq (Hirata et al., 1994b) . Platelets from patients homozygous for this mutation showed no aggregation in response to TxA 2 . These results supported the notion that the TxA 2 and TP receptor signaling do indeed play a physiological role in regulating hemostasis.
PGE 2 signaling also acts on smooth muscle cells of the vasculature to regulate blood pressure. To understand which EP receptor is responsible for vessel contraction, Breyer and colleagues administered PGE 2 and PGE analogs intravenously into wild-type and EP2-deficient mice and examined the in vivo response (Kennedy et al., 1999) . They observed that infusion of PGE 2 or an EP2 agonist, butaprost, induced a transient hypotension in wild-type mice, whereas injection of the mixed EP1/3 agonist, sulprostone, resulted in an increase in arterial blood pressure. The hypotensive response to butaprost was not observed in EP2-deficient mice, although the hypertensive effects of sulprostone persisted. Surprisingly, PGE 2 also evoked considerable hypertension in EP2-deficient mice. The authors suggested that the absence of the EP2 receptor abolishes the ability of the mouse vasculature to vasodilate in response to PGE 2 and unmasked a contractile response mediated via interaction with the vasoconstrictor EP receptor(s). Interestingly, when fed a high-salt diet, the EP2-deficient mice developed significant hypertension with a concurrent increase in urinary excretion of PGE 2 . These results indicated that PGE 2 is produced in the body in response to a high-salt diet to decrease blood pressure via the relaxant EP2 receptor and that perturbation of this pathway may be involved in the development of salt-sensitive hypertension. Coffman and colleagues compared the roles of individual EP receptors in males and females and found that the relative contributions of each EP receptor subtype were strikingly different. In females, the EP2 and EP4 receptors mediated the major portion of the vasodepressor response to PGE 2 . However in males, the EP2 receptor had a modest role and most of the vasodepressor effect were mediated by the EP1 receptor coupled to phospholipase C. In addition, the EP3 receptor in male mice actively opposed the vasodepressor actions of PGE 2 . Thus the genetic evidence points to a complex interplay of EP, TP, and IP receptors in regulating cardiovascular homeostasis in mammals.
Given this knowledge about prostaglandin biology in the murine model, can we address a role for COX signaling in embryonic development? The answer is decidedly negative. In the mouse, the maternal contribution of prostaglandins to COXmutant embryos and the severe defects of the reproductive capacity of COX-deficient female mice, severely hindered the studies of the developmental role for prostaglandins free from maternal interference. It has been hypothesized that the maternal contribution of prostaglandins in the placenta allows the prostaglandin-deficient embryos to develop normally (Reese et al., 2000 (Reese et al., , 2001 . Mammalian blastocysts produce high levels of PGE 2 and PGF 2a , supporting this idea and suggesting a critical requirement for these bioactive lipids during blastocyst development (Davis et al., 1983; Dey et al., 1980) . In agreement, murine blastocysts cultured outside of the mother do not survive in the presence of COX inhibitors (personal communication, Wang H, Dey SK, Vanderbilt University Medical Center). Therefore, understanding the developmental function of prostaglandins has been hampered by the lack of a suitable model system.
Zebrafish as a model for dissecting prostaglandin pathway
Recently, FitzGerald and colleagues identified the zebrafish orthologues of genes encoding COX-1 and COX-2 . Zebrafish cyclooxygenases have also been shown to be both genetically and functionally equivalent to their mammalian counterparts. These initial studies extended by our work have shown that antisense morpholino oligonucleotides (MOs) translation interference or pharmacologic inhibitors of COX-1 result in gastrulation arrest, while knockdown of COX-2 fails to produce any discernable phenotype (Cha et al., 2005; Grosser et al., 2002) . This is consistent with our finding that cox1 transcripts were expressed ubiquitously during gastrulation, while cox2 expression was not detected until the end of the gastrula period (Cha et al., 2005) . This finding also supports the role of COX-1 as a ''housekeeping'' enzyme in which a basal level of prostaglandin is required for normal homeostasis.
Zebrafish are an attractive model system in which to address the roles of prostaglandins in embryogenesis for many reasons (Amatruda et al., 2002) . Each pair-wise mating gives rise to hundreds of embryos for study on a weekly basis. Most importantly for prostaglandin biology, embryogenesis occurs outside of mother's body, thus not influenced by maternal prostaglandins. Moreover embryogenesis can be visualized at tissue and cellular levels due to the transparency of the developing embryos; molecular markers are available for virtually all the tissues. Zebrafish embryos and their chorions are highly permeable to many drugs, facilitating a temporal control of inhibition of different enzymes involved in prostaglandin signaling. In addition, forward genetic screens have identified mutations in many developmental pathways, allowing one to study functional interactions between prostaglandin signaling and other developmental pathways.
Blood vessel development
Taking advantage of the extra-embryonic development of zebrafish embryos, we recently further characterized the functional requirements for prostaglandins in early development. After the period of ubiquitous expression during blastula and early gastrula stages, cox1 transcripts became restricted to the posterior intermediate mesoderm during somitogenesis and to posterior mesodermal organs at 24 h post fertilization (hpf), including blood vessel and nephric duct (Table 1) . Partial knockdown of COX-1 expression using moderate doses of MOs or pharmacologic inhibition of its activity after gastrulation both resulted in defective vascular tube formation and shortened intersomitic vessels in the posterior body (Cha et al., 2005) . Using pharmacologic inhibition to identify the critical time window of COX-1 function in blood vessel development revealed that COX-1 is required after the 20 somite stage, when the intermediate cell mass (ICM) undergoes morphogenesis to form the dorsal artery and posterior cardinal vein (Cha et al., 2005) (Fig. 2) . These findings in zebrafish are consistent with our data in the human cell culture model in which human umbilical vein endothelial cells (HUVECs) treated with COX-1 antisense oligonucleotides exhibited defects in endothelial tube formation (Tsujii et al., 1998) , while those treated with COX-2 antisense oligonucleotides did not.
In mammalian systems, mounting evidence supports a critical requirement for cyclooxygenase and its prostaglandin products in angiogenesis. During implantation and decidualization, COX-derived prostaglandins (PGs) are important for uterine vascular permeability and angiogenesis (Matsumoto et al., 2002) . Various studies also indicate that NSAIDs inhibited angiogenesis in vivo (Majima et al., 1997) , primarily by downregulating PGE 2 levels. Additionally, PGE 2 upregulated the production of angiogenic factors (VEGF, bFGF), which are important for the growth and survival of endothelial cells and stimulates vascular endothelial cell proliferation, migration, and tube formation (Iniguez et al., 2003) . In zebrafish, sprouting of the intersomitic vessels from the dorsal aorta occurs by angiogenesis, whereby angioblasts migrate along the dorsal aorta from the posterior lateral mesoderm and sprout at the intersomitic boundaries (Lawson and Weinstein, 2002b) . In embryos in which COX-1 activity was inhibited by indomethacin, approximately 70% of the intersomitic vessels were either shortened or absent at 1 day post-fertilization but somite differentiation occurred normally (Cha et al., 2005) , leading us to hypothesize that lack or inhibition of COX-1 activity was responsible for shortened intersomitic vessel formation in zebrafish, and not by other secondary defects in development such as somite formation. Zebrafish are an established model for studying angiogenesis (Lawson and Weinstein, 2002a) , the role of COX-1 signaling in regulating angiogenesis needs to be further explored in this model system to understand the precise cellular and molecular mechanisms involved.
Cell motility in gastrulation and cancer metastasis
Over the past decade, COX-2 derived prostaglandins have been implicated in the development and progression of many types of cancer (Gupta and Dubois, 2001) . One aspect of this research involves elucidating the mechanisms by which PGE 2 signaling promotes cancer cell invasion and movement during metastasis (Fig. 3 ). Upon stimulation with PGE 2 , cancer cells demonstrated increased proliferation and invasion. Furthermore, the stimulatory effects of PGE 2 were dependent upon the activation of the phosphatidylinositol 3-kinase/Akt pathway (Sheng et al., 2001) , which ultimately induce actin polymerization and, possibly, epithelial -mesenchymal transition, to cause invasion and migration of cancer cells during metastatic spread (Fig. 3) . However these studies were primarily from tumor cell lines in vitro and the cellular behavior and molecular pathways regulated by PGE 2 in vivo are not known. PGE 2 -induced migration and invasion of cancer cells can also occur via rapid transactivation and phosphorylation of the epidermal growth factor receptor (EGFR) both intracellularly (Buchanan et al., 2003) and extracellularly (Pai et al., 2002) , These results supported the notion that the early effects of COX-2-derived PGE 2 are mediated, in part, by activation of the EGFR, and this transactivation is responsible for subsequent downstream effects, including the stimulation of cell migration and invasion.
Assaying the prostaglandin levels in zebrafish embryos (Cha et al., 2005) and adults revealed the presence of PGE 2 , PGI 2 , PGF 2a and low levels of TxA 2 , suggesting the existence of prostaglandin synthases and receptors. In support of this hypothesis, we and others have recently identified the zebrafish orthologues of microsomal prostaglandin E2 synthase (mPGES) (Pini et al., 2005) and EP receptors in zebrafish (YC, LSK, RND, unpublished data). Moreover using antisense morpholino oligonucleotides to inhibit the translation and/or splicing of the PGE 2 signaling cascade components we demonstrated that PGE 2 regulates cell movement during gastrulation via the EP4 receptor in zebrafish (YC, LSK, RND, unpublished data). The similarity between the cancer cell and zebrafish embryo data is quite striking: both models imply that PGE 2 stimulation of EP4 is the key step in regulating cell movement, both systems suggest PI3K/Akt as the key mediator downstream of EP4 signaling, and finally, both models do not implicate other EP receptors in this process, demonstrating that PGE 2 -mediated stimulation of cell movement may be restricted to the EP4 receptor. Additionally in zebrafish, EP4 signaling primarily promotes cell motility, without influencing cell shape or directional movement during gastrulation (YC, LSK and RND, unpublished data). Therefore, understanding the mechanism by which EP4 activates PI3K/ Akt and, furthermore, elucidating how Akt ultimately allows cell movement to occur in zebrafish may provide insight into how PGE 2 regulates cell movement during metastasis.
Outstanding questions and future directions
Zebrafish is an intriguing and promising model, which may allow for a clearer understanding of the precise role of prostaglandins in regulating embryonic development. One pressing question to address is the unexpected pathology concerning the cardiovascular side effects found in humans after prolonged treatment with COX-2 selective inhibitors. In human studies, COX-2 inhibitors appear to affect the formation of prostacyclin (McAdam et al., 1999) , shifting the balance toward a prothrombotic state (Cheng et al., 2002) . Hence, it would be important to address whether this also occurs in adult fish by treating them with a wide variety of COX selective inhibitors. Many of the same genes involved in blood-vessel formation and blood cell development in mammals also have been shown to function in similar ways in zebrafish (Nasevicius et al., 2000) . Therefore, we would expect similar cardiovascular side effects in zebrafish as a result of COX inhibition. In this case, it would become critical to carefully quantitate and analyze these cardiovascular defects which may give insight into the pathophysiology of COX-2 inhibition in humans.
Another intriguing question to address is the function of other types of prostaglandins that exist in zebrafish. Our analysis revealed the presence of EP, IP, and FP receptors in the zebrafish EST database. Genetic knockdown experiments and screenings for mutations in genes encoding each prostaglandin synthase and receptor will undoubtedly provide more insight into how prostaglandins function in early development. Furthermore, the detailed mechanism by which prostaglandins signal to downstream effectors warrant further investigation. We have only begun to uncover some of the downstream effectors of prostaglandin receptors in mammalian systems. Any downstream targets identified in zebrafish can be studied in other model systems as well (mouse or cultured cells) to understand the conserved nature of prostaglandin signaling. Studies in developmental model systems have advanced our understanding of major signaling pathways and, if history provides any indication, studies in zebrafish will undoubtedly give much insight into the detailed mechanism for prostaglandin signaling and function. Based on our findings in zebrafish, it is now important to revisit the mammalian models to analyze embryonic defects associated with inhibition of both maternal and fetal production of prostaglandins.
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